Accordingly, while the functional synergy between dysregulated PI3K/AKT and p53 relays may seem self-explanatory, in clinical practice, such cooperativity remains case-dependent or reaches statistical significance only in certain cancer entities or patient subsets. This evidence concerns the gene TP53 and cancer.